The multiple beneficial effects of FGF21 on glucose and lipid metabolism and insulin sensitivity suggest that it might represent a promising therapeutic agent to treat diabetes and other obesity-related metabolic disorders (9,10). The gene discussed is FGF21; the disease is Obesity.